4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0000950170-25-002046
Options or other derivatives
- President and CEO acquired 625,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
WILSON TROY EDWARD · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-02 | Grant or award : show line 1 in the form Option to purchase common stock | +625,000 | 625,000 | D |
Loading xslF345X05/ownership.xml…